Citizens' Issues
Pedestrian deaths in India could be double than officially stated
More than double the pedestrians die every day on Indian roads that what the official figures suggest, according to a new study.
 
Police reports of the actual toll of road traffic injuries differ substantially from official statistics, the study, published online in the journal Injury Prevention, showed.
 
India's official statistics on road traffic injuries between 2001 and 2014 report that pedestrians comprise fewer than 10 per cent of deaths - unusually low for a country where walking is the most common means of transportation, the researchers said.
 
The actual figures could be more than 20 per cent, meaning that almost one fifth of road accident victims are pedestrians, according to the research.
 
Similarly, the study said, motorcycle deaths are also underrepresented in the official statistics.
 
"Our study suggests that taken together pedestrians and motorcyclists account for the vast majority of traffic deaths in India," said lead author Kavi Bhalla, assistant professor at Johns Hopkins University Bloomberg School of Public Health in Baltimore, Maryland, US.
 
"The Indian government claims that they intend to cut traffic deaths by half, but this is impossible to achieve without knowing how people die on the roads," Bhalla said.
 
In India, traffic police are responsible for investigating road traffic collisions. 
 
The National Crime Records Bureau (NCRB) collects police reports from across the country and collates these to produce the official statistics for road traffic injuries.
 
In a bid to test the accuracy of these figures, the researchers reviewed police First Information Reports (FIR) of road traffic deaths in Belgaum district of Karnataka in 2013 and 2014. 
 
These were then compared with the official stats from the NCRB, and large discrepancies emerged.
 
For example, official statistics for Belgaum reported that only nine per cent of deaths were among pedestrians, but the FIRs showed that in reality pedestrians comprised more than double that ? 21 per cent.
 
Similarly, official government statistics reported that 37 per cent of road traffic deaths were among motorcyclists, but the FIRs showed that they comprised almost half at 49 per cent.
 
While the study is based in only one district, the process of reporting in this district is similar to that used by all districts in the country.
 
The findings therefore suggest that India's official statistics on road traffic deaths are likely to be unreliable, with pedestrians, cyclists and motorcyclists underrepresented, while vehicle occupants are overrepresented, conclude the authors.
 
The researchers noted that there was no substantial discrepancy in the total traffic deaths between the official statistics for the district and their assessment. 
 
The reasons for these apparent discrepancies in official statistics are not clear, the researchers said. One possibility is that official statistics capture the mode of transport for the person judged responsible for the crash rather than reporting how the person who died was travelling.
 
Whatever the cause, until reporting procedures are fixed, researchers and policymakers in India should use data from police case files not official government statistics, Bhalla said.
 
Disclaimer: Information, facts or opinions expressed in this news article are presented as sourced from IANS and do not reflect views of Moneylife and hence Moneylife is not responsible or liable for the same. As a source and news provider, IANS is responsible for accuracy, completeness, suitability and validity of any information in this article.

User

Fosun buys majority stake in Gland Pharma for USD 1.4 billion
Chinese drug giant Shanghai Fosun Pharmaceutical Group Co. Ltd. has bought 86 per cent stake in Gland Pharma for about $1.4 billion.
 
This is billed as India's largest inbound acquisition in 2016.
 
Hong Kong-listed Fosun is controlled by billionaire Guo Guangchang while Hyderabad-based Gland Pharma is backed by global private equity firm KKR & Co.
 
While Fosun bought 86 per cent stake, the rest will remain with the promoter's family, sources in Gland Pharma said.
 
The deal is likely to be announced officially in a day or two.
 
Established in 1978, Gland Pharma has seven factories in Hyderabad and Visakhapatnam, manufacturing a variety of injectables and high quality APIs (active pharmaceutical ingredients).
 
It sells generic injectables, primarily in the US and Europe.
 
Gland had sales of around Rs 1,300 crore last fiscal, with 30 per cent Compound Annual Growth Rate (CAGR).
 
Disclaimer: Information, facts or opinions expressed in this news article are presented as sourced from IANS and do not reflect views of Moneylife and hence Moneylife is not responsible or liable for the same. As a source and news provider, IANS is responsible for accuracy, completeness, suitability and validity of any information in this article.

User

Waterlogging in Gurgaon hits Dehi-Jaipur route
Hundreds of commuters on the Delhi-Jaipur route remained stuck on National Highway 8 after heavy rain left the Hero Honda Chowk here inundated, officials said on Friday.
 
As NH 8 remained cut off, traffic moving towards Rajasthan and Maharashtra was stuck on the city roads and state highways throughout Thursday night.
 
Around 1 a.m. on Friday, the water level started rising. The scared and stranded people pulled down a part of the divider on Delhi-Gurgaon expressway to escape.
 
It would take few more hours to restore the traffic, officials said. 
 
People demanded action against officials responsible for the situation.
 
The traffic situation in the city is expected to remain critical on Friday.
 
Disclaimer: Information, facts or opinions expressed in this news article are presented as sourced from IANS and do not reflect views of Moneylife and hence Moneylife is not responsible or liable for the same. As a source and news provider, IANS is responsible for accuracy, completeness, suitability and validity of any information in this article.

User

We are listening!

Solve the equation and enter in the Captcha field.
  Loading...
Close

To continue


Please
Sign Up or Sign In
with

Email
Close

To continue


Please
Sign Up or Sign In
with

Email

BUY NOW

The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)